STEVEN C. GILMAN

Insider Reports History

Location
Lexington, MA
Signature
/s/ Robert F. Joyce Jr., by Power of Attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by STEVEN C. GILMAN:

Company Role Class Num Shares Value Price $ Report Date Ownership
Vericel Corp Director Common Stock 11,000 $454,960 $41.36 16 Oct 2024 Direct
Akebia Therapeutics, Inc. Director Common Stock 152,830 $400,414 $2.62 10 Jun 2025 Direct
SCYNEXIS INC Director Common stock 70,000 $67,200 $0.9600 26 Jun 2025 Direct
Vericel Corp Director Restricted Stock Unit 3,200 $57,600 $18.00 01 May 2024 Direct
Akebia Therapeutics, Inc. Director Stock Option (Right to buy) 53,600 10 Jun 2025 Direct
CONTRAFECT Corp Director Options (Right to Buy) 42,000 17 May 2022 Direct
SCYNEXIS INC Director Stock Option 23,000 26 Jun 2025 Direct
Vericel Corp Director Stock Option (Right to Buy) 0 16 Oct 2024 Direct

Insider Reports Filed by STEVEN C. GILMAN

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SCYX SCYNEXIS INC 26 Jun 2025 2 $0 4 Director 30 Jun 2025, 16:09
AKBA Akebia Therapeutics, Inc. 10 Jun 2025 2 $0 4 Director 11 Jun 2025, 17:14
VCEL Vericel Corp 16 Oct 2024 3 -$165,132 4 Director 18 Oct 2024, 16:05
VCEL Vericel Corp 02 Oct 2024 3 -$159,241 4 Director 04 Oct 2024, 16:06
VCEL Vericel Corp 18 Sep 2024 3 -$189,547 4 Director 20 Sep 2024, 16:05
VCEL Vericel Corp 04 Sep 2024 3 -$224,200 4 Director 05 Sep 2024, 16:06
SCYX SCYNEXIS INC 20 Jun 2024 2 $0 4 Director 21 Jun 2024, 16:08
AKBA Akebia Therapeutics, Inc. 06 Jun 2024 2 $0 4 Director 10 Jun 2024, 16:19
VCEL Vericel Corp 01 May 2024 4 $0 4 Director 03 May 2024, 16:06
SCYX SCYNEXIS INC 15 Jun 2023 1 $0 4 Director 23 Jun 2023, 16:12
SCYX SCYNEXIS INC 15 Jun 2023 1 $0 4 Director 20 Jun 2023, 20:00
AKBA Akebia Therapeutics, Inc. 06 Jun 2023 2 $0 4 Director 08 Jun 2023, 16:07
VCEL Vericel Corp 03 May 2023 2 $0 4 Director 05 May 2023, 16:04
VCEL Vericel Corp 27 Apr 2023 2 $0 4 Director 28 Apr 2023, 16:04
SCYX SCYNEXIS INC 17 Jun 2022 2 $0 4 Director 22 Jun 2022, 16:03
AKBA Akebia Therapeutics, Inc. 08 Jun 2022 2 $0 4 Director 09 Jun 2022, 16:58
AKBA Akebia Therapeutics, Inc. 03 Jun 2022 1 -$1,653 4 Director 07 Jun 2022, 16:03
/report/000120919122030206-gilman-steven-c-2022-05-17 CONTRAFECT Corp 17 May 2022 1 +$140,700 4 Director 18 May 2022, 18:04
VCEL Vericel Corp 29 Apr 2022 1 -$27,846 4 Director 02 May 2022, 16:07
VCEL Vericel Corp 27 Apr 2022 4 $0 4 Director 29 Apr 2022, 16:12
VCEL Vericel Corp 29 Nov 2021 3 -$177,155 4 Director 01 Dec 2021, 15:07
VCEL Vericel Corp 27 Oct 2021 3 -$234,170 4 Director 28 Oct 2021, 16:12
VCEL Vericel Corp 30 Sep 2021 3 -$225,555 4 Director 01 Oct 2021, 16:12
SCYX SCYNEXIS INC 16 Jun 2021 1 $0 4 Director 21 Jun 2021, 08:29
AKBA Akebia Therapeutics, Inc. 07 Jun 2021 1 -$15,163 4 Director 09 Jun 2021, 16:26
AKBA Akebia Therapeutics, Inc. 02 Jun 2021 2 $0 4 Director 03 Jun 2021, 17:26
/report/000120919121034651-gilman-steven-c-2021-05-18 CONTRAFECT Corp 18 May 2021 1 $0 4 Director 20 May 2021, 19:48